• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Rapamycin eluting stent: the onset of a new era in interventional cardiology.雷帕霉素洗脱支架：介入心脏病学新时代的开端。
Heart. 2002 Apr;87(4):305-7. doi: 10.1136/heart.87.4.305.
2
The porcine coronary model of in-stent restenosis: current status in the era of drug-eluting stents.猪冠状动脉支架内再狭窄模型：药物洗脱支架时代的现状
Catheter Cardiovasc Interv. 2003 Dec;60(4):515-23. doi: 10.1002/ccd.10705.
3
Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.用于基于支架的局部药物递送的雷帕霉素类似物。依维莫司和他克莫司洗脱支架。
Herz. 2004 Mar;29(2):162-6. doi: 10.1007/s00059-004-2556-6.
4
Sirolimus-eluting coronary stent.西罗莫司洗脱冠状动脉支架
Am J Health Syst Pharm. 2004 Mar 1;61(5):449-56. doi: 10.1093/ajhp/61.5.449.
5
ABT-578-eluting stents. The promising successor of sirolimus- and paclitaxel-eluting stent concepts?ABT-578洗脱支架。西罗莫司和紫杉醇洗脱支架概念的有望继任者？
Herz. 2004 Mar;29(2):167-70. doi: 10.1007/s00059-004-2557-5.
6
The impact of Sirolimus Eluting stents in interventional cardiology.
Int J Cardiol. 2004 Jun;95(2-3):117-21. doi: 10.1016/j.ijcard.2003.10.010.
7
[Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].[德国西罗莫司洗脱冠状动脉支架“实际使用”中的安全性及当前适应证。德国前瞻性多中心西罗莫司洗脱支架注册研究结果]
Herz. 2004 Mar;29(2):181-6. doi: 10.1007/s00059-004-2560-x.
8
[Drug-eluting stents and other anti-restenosis devices].药物洗脱支架及其他抗再狭窄装置
Rev Esp Cardiol. 2005 Jul;58(7):842-62.
9
Is there delayed restenosis in patients with coronary artery disease treated with sirolimus-eluting stent?
Coron Artery Dis. 2007 Jun;18(4):293-8. doi: 10.1097/MCA.0b013e32812cba31.
10
Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coating.一种具有剂量可调节、无聚合物、现场支架涂层的新型药物洗脱支架系统预防再狭窄。
Eur Heart J. 2005 Aug;26(15):1475-81. doi: 10.1093/eurheartj/ehi405. Epub 2005 Jun 23.

引用本文的文献

1
Targeting mTOR in myeloid cells prevents infection-associated inflammation.靶向髓系细胞中的mTOR可预防感染相关炎症。
iScience. 2025 Mar 4;28(4):112163. doi: 10.1016/j.isci.2025.112163. eCollection 2025 Apr 18.
2
Platelet membrane-modified exosomes targeting plaques to activate autophagy in vascular smooth muscle cells for atherosclerotic therapy.靶向斑块的血小板膜修饰外泌体激活血管平滑肌细胞自噬以治疗动脉粥样硬化
Drug Deliv Transl Res. 2025 Jan 28. doi: 10.1007/s13346-025-01792-1.
3
Biofunctional coatings and drug-coated stents for restenosis therapy.用于再狭窄治疗的生物功能涂层和药物涂层支架。
Mater Today Bio. 2024 Sep 19;29:101259. doi: 10.1016/j.mtbio.2024.101259. eCollection 2024 Dec.
4
Loss of Macrophage mTORC2 Drives Atherosclerosis via FoxO1 and IL-1β Signaling.巨噬细胞 mTORC2 的缺失通过 FoxO1 和 IL-1β 信号通路驱动动脉粥样硬化。
Circ Res. 2023 Jul 21;133(3):200-219. doi: 10.1161/CIRCRESAHA.122.321542. Epub 2023 Jun 23.
5
Recent Advances in Stent Technology: Do They Reduce Cardiovascular Events?支架技术的最新进展：它们是否降低心血管事件？
Curr Atheroscler Rep. 2022 Sep;24(9):731-744. doi: 10.1007/s11883-022-01049-z. Epub 2022 Jul 11.
6
Modulating mTOR Signaling as a Promising Therapeutic Strategy for Atherosclerosis.调节 mTOR 信号作为动脉粥样硬化有前途的治疗策略。
Int J Mol Sci. 2022 Jan 21;23(3):1153. doi: 10.3390/ijms23031153.
7
Genotype and Trait Specific Responses to Rapamycin Intake in .. 中雷帕霉素摄入的基因型和性状特异性反应
Insects. 2021 May 20;12(5):474. doi: 10.3390/insects12050474.
8
A Multilayer Functionalized Drug-Eluting Balloon for Treatment of Coronary Artery Disease.一种用于治疗冠状动脉疾病的多层功能化药物洗脱球囊。
Pharmaceutics. 2021 Apr 23;13(5):614. doi: 10.3390/pharmaceutics13050614.
9
Sirolimus-eluting stents: opposite effects on the clonogenic cell potential on a long-term exposure.西罗莫司洗脱支架：长期暴露对克隆形成细胞潜能的相反影响。
Oncotarget. 2020 Aug 4;11(31):2973-2981. doi: 10.18632/oncotarget.27554.
10
FK506 regulates Ca release evoked by inositol 1,4,5-trisphosphate independently of FK-binding protein in endothelial cells.FK506在内皮细胞中独立于FK结合蛋白调节由肌醇1,4,5 -三磷酸引发的钙释放。
Br J Pharmacol. 2020 Mar;177(5):1131-1149. doi: 10.1111/bph.14905. Epub 2020 Jan 26.

本文引用的文献

1
Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up.西罗莫司洗脱支架消除冠状动脉再狭窄：欧洲首例6个月血管造影和血管内超声随访的人体经验。
Eur Heart J. 2001 Nov;22(22):2125-30. doi: 10.1053/euhj.2001.2892.
2
Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model.基于支架的西罗莫司递送可减少猪冠状动脉模型中的新生内膜形成。
Circulation. 2001 Sep 4;104(10):1188-93. doi: 10.1161/hc3601.093987.
3
Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: Detection of FK506-binding protein 12 upregulation.通过螺旋切割器旋切术获取的微观标本进行cDNA阵列分析，对人支架诱导新生内膜进行基因表达谱分析：检测FK506结合蛋白12上调。
Circulation. 2001 Mar 13;103(10):1396-402. doi: 10.1161/01.cir.103.10.1396.
4
Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study.西罗莫司涂层支架植入人体冠状动脉后无新生内膜增殖：一项冠状动脉定量血管造影和三维血管内超声研究。
Circulation. 2001 Jan 16;103(2):192-5. doi: 10.1161/01.cir.103.2.192.
5
Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle.通过靶向细胞周期调节因子抑制猪冠状动脉球囊血管成形术后内膜增厚。
Circulation. 1999 Apr 27;99(16):2164-70. doi: 10.1161/01.cir.99.16.2164.
6
Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor.免疫抑制药物对血小板衍生生长因子或内皮细胞生长因子刺激的人及大鼠主动脉平滑肌和内皮细胞增殖的不同抑制作用。
J Heart Lung Transplant. 1997 May;16(5):484-92.
7
Rapamycin inhibits vascular smooth muscle cell migration.雷帕霉素抑制血管平滑肌细胞迁移。
J Clin Invest. 1996 Nov 15;98(10):2277-83. doi: 10.1172/JCI119038.
8
Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels.
Transplantation. 1993 Jun;55(6):1409-18. doi: 10.1097/00007890-199306000-00037.
9
Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement.雷帕霉素和霉酚酸治疗可减轻机械损伤所致的动脉内膜增厚，并促进内皮细胞替代。
Transplantation. 1995 Mar 15;59(5):655-61. doi: 10.1097/00007890-199503150-00002.
10
Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells.雷帕霉素 - FKBP抑制血管平滑肌细胞增殖的细胞周期调节因子。
Circ Res. 1995 Mar;76(3):412-7. doi: 10.1161/01.res.76.3.412.

Rapamycin eluting stent: the onset of a new era in interventional cardiology.

作者信息

Serruys P W, Regar E, Carter A J

出版信息

Heart. 2002 Apr;87(4):305-7. doi: 10.1136/heart.87.4.305.

DOI:10.1136/heart.87.4.305
PMID:11906992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1767071/
Abstract
摘要